Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer.
Animals
Antibodies, Monoclonal, Humanized
/ immunology
Antineoplastic Agents
/ immunology
B7-H1 Antigen
/ antagonists & inhibitors
Cell Line, Tumor
Disease Models, Animal
Female
Ferrosoferric Oxide
Immunity
/ immunology
Magnetic Resonance Imaging
/ methods
Mice
Nanoparticles
Proto-Oncogene Proteins B-raf
/ antagonists & inhibitors
Thyroid Carcinoma, Anaplastic
/ diagnostic imaging
Tumor-Associated Macrophages
/ immunology
Journal
Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
28
10
2020
medline:
27
4
2021
entrez:
27
10
2020
Statut:
ppublish
Résumé
Background Anaplastic thyroid cancer (ATC) is aggressive with a poor prognosis, partly because of the immunosuppressive microenvironment created by tumor-associated macrophages (TAMs). Purpose To understand the relationship between TAM infiltration, tumor vascularization, and corresponding drug delivery by using ferumoxytol-enhanced MRI and macrin in an ATC mouse model. Materials and Methods ATC tumors were generated in 6-8-week-old female B6129SF1/J mice through intrathyroid injection to model orthotopic tumors, or intravenously to model hematogenous metastasis, and prospectively enrolled randomly into treatment cohorts (
Identifiants
pubmed: 33107799
doi: 10.1148/radiol.2020201791
pmc: PMC7771993
mid: NIHMS1658248
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
Antineoplastic Agents
0
B7-H1 Antigen
0
atezolizumab
52CMI0WC3Y
Proto-Oncogene Proteins B-raf
EC 2.7.11.1
Ferrosoferric Oxide
XM0M87F357
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
123-132Subventions
Organisme : NCI NIH HHS
ID : T32 CA079443
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA206997
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA257623
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA206890
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA207744
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Clin Cancer Res. 2017 Sep 1;23(17):5024-5033
pubmed: 28512174
Cell. 2017 Nov 2;171(4):934-949.e16
pubmed: 29033130
Med Mol Morphol. 2018 Mar;51(1):57-63
pubmed: 29218457
Br J Cancer. 2018 Nov;119(10):1223-1232
pubmed: 30327563
Oncotarget. 2016 Mar 29;7(13):17194-211
pubmed: 26943572
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7750-5
pubmed: 27342857
Immunity. 2016 Feb 16;44(2):343-54
pubmed: 26872698
ACS Nano. 2018 Dec 26;12(12):12015-12029
pubmed: 30508377
Oncotarget. 2014 Jun 30;5(12):3996-4010
pubmed: 24994118
Sci Transl Med. 2017 May 31;9(392):
pubmed: 28566423
Sci Adv. 2020 May 22;6(21):eaaz8521
pubmed: 32494745
Nanotheranostics. 2017 Jul 6;1(3):296-312
pubmed: 29071194
Magn Reson Med. 2018 Sep;80(3):1138-1147
pubmed: 29327789
Int J Endocrinol. 2019 Feb 19;2019:8428547
pubmed: 30915116
Lab Anim Sci. 1999 Jun;49(3):319-23
pubmed: 10403450
Endocr Relat Cancer. 2008 Dec;15(4):1069-74
pubmed: 18719091
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
PLoS One. 2013 Aug 28;8(8):e73215
pubmed: 24015297
AJNR Am J Neuroradiol. 2018 Mar;39(3):547-551
pubmed: 29242360
Per Med. 2011 Mar;8(2):175-182
pubmed: 29783410
Clin Cancer Res. 2017 Jul 15;23(14):3638-3648
pubmed: 28159813
Cancer Cell. 2017 Nov 13;32(5):654-668.e5
pubmed: 29136508
Adv Drug Deliv Rev. 2015 Aug 30;91:3-6
pubmed: 25579058
J Clin Oncol. 2018 Jan 1;36(1):7-13
pubmed: 29072975
Nat Commun. 2017 Feb 08;8:14293
pubmed: 28176769
Clin Cancer Res. 2018 Sep 1;24(17):4110-4118
pubmed: 29764855
Sci Transl Med. 2017 May 10;9(389):
pubmed: 28490665
Thyroid. 2019 Jul;29(7):979-992
pubmed: 30938231
Int J Cancer. 1988 Apr 15;41(4):562-7
pubmed: 3128489
Nat Biomed Eng. 2018 Aug;2(8):578-588
pubmed: 31015631
Thyroid. 2017 May;27(5):672-681
pubmed: 28068873
Nat Commun. 2015 Oct 27;6:8692
pubmed: 26503691
Sci Transl Med. 2015 Nov 18;7(314):314ra183
pubmed: 26582898
BMC Med Imaging. 2015 Jun 16;15:19
pubmed: 26076957